Gate2Brain
  • Home
  • Company
  • Team
  • Technology
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Posts

Press clippingg2b

Press-Clipping – Gate2Brain receives €2,5M funding to develop a technology that enhances drug delivery to the brain

Clipping
Press-Clipping (All articles)        
January 30, 2023
https://gate2brain.com/wp-content/uploads/2023/01/Negro-Blanco-Entretenimiento-Noticias-Publicacion-de-Instagram.png 1080 1080 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2023-01-30 09:40:112023-01-30 09:49:17Press-Clipping – Gate2Brain receives €2,5M funding to develop a technology that enhances drug delivery to the brain
Team Sant Joan de Deu

Gate2Brain receives €2,5M funding to develop a technology that enhances drug delivery to the brain

Press releases
  EIC Accelerator 2022
December 23, 2022
https://gate2brain.com/wp-content/uploads/2022/12/Sant-Joan-de-Deu-Pediatric-Hospital.jpg 768 1024 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-12-23 09:04:142022-12-23 09:14:42Gate2Brain receives €2,5M funding to develop a technology that enhances drug delivery to the brain

CATEGORIES

  • Clipping
  • Events
  • News
  • Podcast
  • Press releases
  • Publications
  • Videos

Events

  • 📢 On December 13h, Gate2Brain will be participating together with Maribel Berges (AFFIRMA BIOTECH SL), Sven Dr. Mulfinger (Dana_positive maternal health), and Diana Ballart (The Smart Lollipop) in the i4kids Closing Event 2022, sharing achievements and failures of entrepreneurs in #pediatric and maternal #healthcare.i4kidsi4kids Closing Event 2022December 7, 2022 - 12:37
  • WomenStartupAwards, in the "Inspiration" category.WomeninTechSpainFinalist of Women Startup AwardsNovember 15, 2022 - 17:46
  • GORDON CONFERENCESgate2brainGordon Research ConferencesNovember 3, 2022 - 11:41
  • Gate2Brain's retreat 2022Gate2BrainGate2Brain’s retreat 2022October 24, 2022 - 19:27
  • BIO EUROPE 2022GATE2BRAINGate2Brain at BIO-EUROPE 2022September 22, 2022 - 13:39

SOCIAL

  • linkedin
  • youtube

RSS RSS Ciencia

  • What will the d·Health Barcelona Part Time program clinical immersion be like? January 24, 2023 biocat
  • Good start to the year in investment and advances in projects at science facilities January 24, 2023 biocat
  • AseBio and Biocat present BIOSPAIN 2023 in Barcelona to over 200 people from the sector January 16, 2023 biocat
  • 2022: Healthcare research and innovation are strategic priorities for Catalonia December 23, 2022 biocat
  • 5th edition of CRAASH Barcelona program comes to an end December 21, 2022 biocat
  • Registration now open for presentation of 2022 BioRegion Report December 20, 2022 biocat
  • Open Innovation Forum consolidates role resolving innovation challenges in BioRegion December 20, 2022 biocat
  • AseBio and Biocat to present BIOSPAIN 2023 in Barcelona at public event open to whole ecosystem December 12, 2022 biocat
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}